Good long-term survival after childhood liver transplant

December 26, 2017

(HealthDay)—Liver transplantation in childhood is associated with good long-term survival, according to a study published online Dec. 15 in the American Journal of Transplantation.

Josefina Martinelli, M.D., from the Université Paris-Sud, and colleagues examined the outcomes of 128 children who underwent deceased from 1988 to 1993 (median age, 2.5 years). Participants were followed for a median of 24 years.

The researchers found that the 20-year patient survival rate was 79 percent and that the 20-year graft survival rate was 64 percent. Forty-two percent of survivors had elevated serum aminotransferase and/or gamma-glutamyl transferase activities after a single transplantation. In graft histology of 35 patients, 11 showed signs of chronic rejection and and five of biliary obstruction. Patients with abnormal and normal serum liver tests had mean total fibrosis scores of 4.5 and 3 out of 9, respectively. In 35 survivors, including four in end-stage renal disease who were undergoing dialysis or had undergone renal transplantation, the was less than 90 mL/min. The median final heights were 159 and 172 cm for women and men, respectively; in 37 patients, final height was below the target height.

"Twenty-year survival after childhood liver transplantation may be close to 80 percent, and final height is within the normal range for most patients," the authors write. "However, or altered liver biochemistries are present in over one-third of , which is a matter of concern for the future."

Explore further: 20-year survival expected for 4 out of 5 children who receive liver transplants

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

20-year survival expected for 4 out of 5 children who receive liver transplants

April 14, 2016
A new study presented today shows that 20-year survival after childhood liver transplantation can be expected for almost 80% of patients. The study, presented at The International Liver CongressTM 2016 in Barcelona, Spain, ...

ABO incompatible dual graft living donor liver transplant viable

August 3, 2017
(HealthDay)—Dual-graft (DG) adult living donor liver transplantation (ALDLT) with ABO-incompatible (ABOi) and ABO-compatible (ABOc) graft combination is associated with high rates of graft survival, with no significant ...

Drinking coffee may slow progression of liver disease

February 26, 2016
(HealthDay)—Regular coffee consumption seems to delay disease progression in alcoholic liver disease (ALD) and primary sclerosing cholangitis (PSC) patients with end-stage liver disease (ESLD) and increase long-term survival ...

First-degree relative grafts don't up liver disease recurrence

April 25, 2016
(HealthDay)—In liver transplantation (LT), patients who receive living donor grafts from first-degree relatives due to autoimmune liver diseases are not prone to increased disease recurrence, compared to those who receive ...

Good survival for HSCT-treated thalassemia patients

September 13, 2017
(HealthDay)—Patients with thalassemia treated with hematopoietic stem cell transplantation (HSCT) have 30-year survival that is similar to that of conventionally treated (CT) patients, according to a study published online ...

Long-term benefits to the liver-kidney transplant

April 15, 2016
A new study from physicians at Mayo Clinic in Rochester, found there may be long-term benefits to simultaneous liver-kidney transplantation versus kidney transplantation alone. The study, "Decreased Chronic Cellular and Antibody-Mediated ...

Recommended for you

Consuming caffeine from coffee reduces incident rosacea

October 22, 2018
(HealthDay)—Caffeine intake from coffee is inversely associated with the risk for incident rosacea, according to a study published online Oct. 17 in JAMA Dermatology.

Home-based biofeedback therapy is effective option for tough-to-treat constipation

October 22, 2018
Biofeedback therapy used at home is about 70 percent effective at helping patients learn how to coordinate and relax bowel muscles and relieve one of the most difficult-to-treat types of constipation, investigators report.

New hope for cystic fibrosis

October 19, 2018
A new triple-combination drug treatment being trialled at the Mater Hospital in Brisbane could increase the life expectancy of patients with cystic fibrosis.

Bug guts shed light on Central America Chagas disease

October 18, 2018
In Central America, Chagas disease, or American trypanosomiasis, is spread by the "kissing bug" Triatoma dimidiata. By collecting DNA from the guts of these bugs, researchers reporting in PLOS Neglected Tropical Diseases ...

Rapid genomic sequencing of Lassa virus in Nigeria enabled real-time response to 2018 outbreak

October 18, 2018
Mounting a collaborative, real-time response to a Lassa fever outbreak in early 2018, doctors and scientists in Nigeria teamed up with researchers at Broad Institute of MIT and Harvard and colleagues to rapidly sequence the ...

Researchers cure drug-resistant infections without antibiotics

October 17, 2018
Biochemists, microbiologists, drug discovery experts and infectious disease doctors have teamed up in a new study that shows antibiotics are not always necessary to cure sepsis in mice. Instead of killing causative bacteria ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.